118 related articles for article (PubMed ID: 38095592)
1. Enhancement of dissolution rate and oral bioavailability of poorly soluble drug florfenicol by using solid dispersion and effervescent disintegration technology.
Li C; Li N; Chen X; Li X; Liu C; Abbas A; Wang Y; Qi S; Zhang Y; Li D; Zhang W; Shu G; Lin J; Li H; Xu F; Peng G; Fu H
Drug Dev Ind Pharm; 2024 Jan; 50(1):45-54. PubMed ID: 38095592
[TBL] [Abstract][Full Text] [Related]
2. Stiripentol Enteric Solid Dispersion-Loaded Effervescent Tablets: Enhanced Dissolution, Stability, and Absorption.
Wang Y; Xu S; Xiao Z; Jiang Y; Jiang Q; Li J; He W
AAPS PharmSciTech; 2022 May; 23(5):141. PubMed ID: 35538376
[TBL] [Abstract][Full Text] [Related]
3. Piperine fast disintegrating tablets comprising sustained-release matrix pellets with enhanced bioavailability: formulation,
Zhu Y; Yu J; Zhou G; Gu Z; Adu-Frimpong M; Deng W; Yu J; Xu X
Pharm Dev Technol; 2020 Jun; 25(5):617-624. PubMed ID: 32009511
[TBL] [Abstract][Full Text] [Related]
4. It is Possible to Achieve Tablets With Good Tabletability From Solid Dispersions - The Case of the High Dose Drug Gemfibrozil.
Bigogno ER; Soares L; Mews MHR; Zétola M; Bazzo GC; Stulzer HK; Pezzini BR
Curr Drug Deliv; 2021; 18(4):460-470. PubMed ID: 33100203
[TBL] [Abstract][Full Text] [Related]
5. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
[TBL] [Abstract][Full Text] [Related]
6. Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.
Liu Y; Wang T; Ding W; Dong C; Wang X; Chen J; Li Y
Drug Deliv Transl Res; 2018 Jun; 8(3):580-590. PubMed ID: 29450806
[TBL] [Abstract][Full Text] [Related]
7. Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.
Aldosari BN; Almurshedi AS; Alfagih IM; AlQuadeib BT; Altamimi MA; Imam SS; Hussain A; Alqahtani F; Elzayat E; Alshehri S
AAPS PharmSciTech; 2021 May; 22(5):161. PubMed ID: 34031791
[TBL] [Abstract][Full Text] [Related]
8. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
[TBL] [Abstract][Full Text] [Related]
9. Soluplus
Basha M; Salama A; Noshi SH
Drug Dev Ind Pharm; 2020 Feb; 46(2):253-263. PubMed ID: 31937139
[TBL] [Abstract][Full Text] [Related]
10. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
Dehghani H; Taheri A; Homayouni A
Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
[TBL] [Abstract][Full Text] [Related]
11. Torsemide Fast Dissolving Tablets: Development, Optimization Using Box-Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment.
El-Shenawy AA; Ahmed MM; Mansour HF; Abd El Rasoul S
AAPS PharmSciTech; 2017 Aug; 18(6):2168-2179. PubMed ID: 28050711
[TBL] [Abstract][Full Text] [Related]
12. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
Moutasim MY; ElMeshad AN; El-Nabarawi MA
Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization.
M Tawfeek H; Hassan YA; Aldawsari MF; H Fayed M
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33291402
[TBL] [Abstract][Full Text] [Related]
14. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
15. Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability.
Desai S; Poddar A; Sawant K
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():826-34. PubMed ID: 26478377
[TBL] [Abstract][Full Text] [Related]
16. Comparative muscle irritation and pharmacokinetics of florfenicol-hydroxypropyl-β-cyclodextrin inclusion complex freeze-dried powder injection and florfenicol commercial injection in beagle dogs.
Fan G; Zhang L; Shen Y; Shu G; Yuan Z; Lin J; Zhang W; Peng G; Zhong Z; Yin L; Fu H
Sci Rep; 2019 Nov; 9(1):16739. PubMed ID: 31723173
[TBL] [Abstract][Full Text] [Related]
17. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
[TBL] [Abstract][Full Text] [Related]
18. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
Surampalli G; Nanjwade BK; Patil PA; Chilla R
Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
20. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
Zhang S; Xu X; Sun W; Zhang Z; Pan B; Hu Q
Eur J Pharm Sci; 2022 Jan; 168():106074. PubMed ID: 34798261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
